clinical pharmacologyiclinical trials
Describe in detail, the clinical pharmacology support studies (not the single ascending dose study, multiple ascending dose study, Phase II or Ill studies) that are typically done for a small molecule entity (SME), but NOT for a monoclonal antibody (MAB), giving the rationale for why they are not required to be done for the antibody.